id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
yytR5KVWEemH9buFb89OWw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,signal regulatory protein-a,"addition, the mRNA abundance of ", (SIRPα) was significantly reduc,TextQuoteSelector,TextPositionSelector,15738,15765,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:13:00.383984+00:00
yCV4HKVbEemUac8gbzRsmA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,sepsis,"ion [19], peritonitis [20], and ", [21]. In addition to polarizati,TextQuoteSelector,TextPositionSelector,32854,32860,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:48:42.681886+00:00
y4bozKVTEem-QkNR2OvQlg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1,"rophages, inflammation, cancer, ",Go to:INTRODUCTIONCancers develo,TextQuoteSelector,TextPositionSelector,11480,11484,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:51:32.416718+00:00
xvv0pqVXEemHNKM6R4oVBA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,breast cancer,o-injected with MDA-MB-231-FLUC ," cells, the cMSCs but not the un",TextQuoteSelector,TextPositionSelector,17244,17257,WS_DS,yes,[WS_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:20:02.676958+00:00
xqMJxKVaEem7Mj8x8ljMlg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,mammary cancer,y cMSCs stimulate the growth of ," cells in vivo, we injected 4T1-",TextQuoteSelector,TextPositionSelector,28589,28603,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:41:30.775901+00:00
xaj4PKVdEem3mV9jCLZmhA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,nitric oxide synthase,and rabbit anti-mouse inducible , (iNOS) and CD206 monoclonal ant,TextQuoteSelector,TextPositionSelector,36263,36284,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:02:57.633608+00:00
xIbznLQ-EemeD7PXVgKGmQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs could favor the tumor,"ffects. Here, we tested whether ", to escape from immunologic surv,TextQuoteSelector,TextPositionSelector,10617,10643,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:28:48.655801+00:00
x2pP2qVeEemMtqcBwRBK5Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,cotton,face was cleaned with a sterile ," swab, and the burr hole was fil",TextQuoteSelector,TextPositionSelector,38093,38099,WT_OG,no,[WT_OG],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:10:10.073479+00:00
wyk36KVYEemOcQddHvro6Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,COX-2," levels of iNOS, MCP1, IL-6 and ", were markedly higher in the cMS,TextQuoteSelector,TextPositionSelector,19132,19137,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:27:05.956257+00:00
wjAHEKeVEemgsDNjV9A0OA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,chemokine receptor,e.MCP-1 is the CCR2 ligand. The , CCR2 is known to be expressed o,TextQuoteSelector,TextPositionSelector,25912,25930,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:48:45.810278+00:00
wZPL_KVWEemV6LsrjVHGxQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,FIZZ-1,"al M2 markers (IL-10, Arg-1 and ",") in M1 macrophages, but in our ",TextQuoteSelector,TextPositionSelector,15599,15605,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:12:44.204109+00:00
wR9S4KVbEem7NUd5uzewZA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,peritonitis,"ing myocardial infarction [19], "," [20], and sepsis [21]. In addit",TextQuoteSelector,TextPositionSelector,32832,32843,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:48:31.040641+00:00
wQcyxKVfEems7mcb0U43rA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,donkey,ors. Alexa Fluor 594-conjugated , anti-rat secondary antibody (BD,TextQuoteSelector,TextPositionSelector,42581,42587,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:17:08.744942+00:00
v8txyqVhEem1aAsD_7gRhQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,interleukin-19,"umor necrosis factor-α (TNF-α), "," (IL-19), matrix metalloproteina",TextQuoteSelector,TextPositionSelector,40816,40830,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:31:25.658196+00:00
uwimFqVTEem-AB9BDY69nQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-6,"nt to tumor sites. Furthermore, ", secreted by the cMSCs could pol,TextQuoteSelector,TextPositionSelector,11157,11161,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:51:04.828898+00:00
uIXrbqVeEemEJFM47jd5GQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,brain tumor,ALB/c nude mice. For orthotopic ," models, 10 μl of 2 × 105 U87MG-",TextQuoteSelector,TextPositionSelector,37862,37873,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:09:45.047742+00:00
uGAXDKVbEemLInMofi2hDQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,inflammatory associated disease,ry environment has been used in ,", including myocardial infarctio",TextQuoteSelector,TextPositionSelector,32761,32792,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:48:16.250382+00:00
u24oXLQ-Eem63VtcE5kYvA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs responded to adopting an immune regulatory phenotype to dampen inflammation and promote tumor ,"cytokines in the M1 medium, the ",growth. Our research may inspire,TextQuoteSelector,TextPositionSelector,35639,35738,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:28:33.368324+00:00
tsKYlKVaEemZCqszYfENFw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,SIRPα ,"high levels of FIZZ-1, MCP1 and ","(Figure ​(Figure5A),5A), compris",TextQuoteSelector,TextPositionSelector,28015,28021,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:41:04.016772+00:00
tsH9oKVdEemZFzOJv6X35A,b53nbDmi,https://europepmc.org/articles/PMC4991502/,rabbit,b were from BD Biosciences; and , anti-mouse inducible nitric oxi,TextQuoteSelector,TextPositionSelector,36235,36241,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:02:32.524780+00:00
tjUytKVWEemQpofiMZW-Zg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Arg-1,"l of several M2 markers (IL-10, "," and FIZZ-1) in M1 macrophages, ",TextQuoteSelector,TextPositionSelector,15589,15594,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:12:25.111369+00:00
tbOc7rQ-EemjE3e6sQkeyg,b53nbDmi,https://europepmc.org/articles/PMC4991502/," iNOS gene knockdown, the immune suppression and tumor",ccurred via iNOS in vitro. After, growth enhancement of the cMSCs,TextQuoteSelector,TextPositionSelector,34448,34502,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:28:23.785698+00:00
tOUpoKeVEemm2hMAIYH6CA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,membrane receptor,educed (Figure S1A). SIRPα is a , expressed by macrophages. The i,TextQuoteSelector,TextPositionSelector,15825,15842,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:48:23.383192+00:00
sqfFNKVXEem8Is9p7ANRDA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,carcinoma,mmune deficient mice with human ," cells, while untreated MSCs wer",TextQuoteSelector,TextPositionSelector,17145,17154,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:19:28.674526+00:00
sLr-BqVZEemLFyuUpMh8bQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumors,he bioluminescent signal (C) in , after treatments.MCP1-mediated ,TextQuoteSelector,TextPositionSelector,24008,24014,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:33:44.433443+00:00
rzLinrQ-Eem5pYvUncKoqA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs secrete a number of paracrine factors that may influence tumor,itro [24]. It is clear that the ," growth [25, 26]. However, the e",TextQuoteSelector,TextPositionSelector,33920,33987,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:28:12.885193+00:00
rvnUEqVTEemD9CsF3ub9tQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1,pressed high levels of iNOS and ,. Consistent with an elevated MC,TextQuoteSelector,TextPositionSelector,10979,10983,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:50:44.604273+00:00
rheijKVcEem2r79T13B2ZA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,immune suppression," After iNOS gene knockdown, the ", and tumor growth enhancement of,TextQuoteSelector,TextPositionSelector,34474,34492,WT_DS,no,[WT_DS],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:55:08.542018+00:00
r3Dg4qVeEemMtWuXashmqw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,BALB/c nude mice,ded in saline into the liver of ,. For orthotopic brain tumor mod,TextQuoteSelector,TextPositionSelector,37829,37845,WS_OG,no,WS_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:09:29.834782+00:00
qjC9qKVWEemM_-9YNKOUow,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-10,NA level of several M2 markers (,", Arg-1 and FIZZ-1) in M1 macrop",TextQuoteSelector,TextPositionSelector,15582,15587,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:12:04.909931+00:00
qgzKJKVbEemjEzcw4Wt9LQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,myocardial infarction,"y associated disease, including "," [19], peritonitis [20], and sep",TextQuoteSelector,TextPositionSelector,32804,32825,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:47:52.229284+00:00
qQ3_SqVfEemdpv9ud1rg2w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,GAPDH,NA was normalized to endogenous , mRNA. Real-time PCR was perform,TextQuoteSelector,TextPositionSelector,41060,41065,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:16:28.652323+00:00
qM39srQ-EemgZQ9vRLpLYQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"tumor growth by iNOS, MCP1","enotype, and the cMSCs promoted ", and induced macrophages toward ,TextQuoteSelector,TextPositionSelector,31675,31701,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:28:02.236650+00:00
qH8btqVXEemdiMvzofQxMw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,human,into immune deficient mice with ," carcinoma cells, while untreate",TextQuoteSelector,TextPositionSelector,17139,17144,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:19:11.721591+00:00
pnsJUKVTEemyIYfCwm__6A,b53nbDmi,https://europepmc.org/articles/PMC4991502/,iNOS, which expressed high levels of , and MCP1. Consistent with an el,TextQuoteSelector,TextPositionSelector,10970,10974,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:50:30.363286+00:00
p2j9GqeVEemlIVND4xbUqQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,chemokine ,M1 medium altering the cytokine/,expression in the cMSCsThe MSCs ,TextQuoteSelector,TextPositionSelector,18622,18632,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:48:00.886659+00:00
oflhxqeVEemQBrfDx5Xk9A,b53nbDmi,https://europepmc.org/articles/PMC4991502/,cytokine,lated by M1 medium altering the ,/chemokine expression in the cMS,TextQuoteSelector,TextPositionSelector,18613,18621,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:47:51.698619+00:00
oVLVcKVdEemllt8RSrJmbQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD44,"-mouse antibodies against CD29, ",", CD45, and CD11b were from BD B",TextQuoteSelector,TextPositionSelector,36183,36187,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:01:56.578841+00:00
oD_VZqVYEemrJbfDumMhNw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor,n the cMSCs may account for the ,-promotion activity by the cMSCs,TextQuoteSelector,TextPositionSelector,18849,18854,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:26:07.270881+00:00
o98U0KVcEemy80u-FtdnIQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,melanoma,ve effects by iNOS to favor B16 , cell growth [18]. In our experi,TextQuoteSelector,TextPositionSelector,34327,34335,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:54:51.429128+00:00
o2DIyLQ-EemqbnP4QVCNkg,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor-promoting abilities required iNOS and TAMs; TAMs were recruited by MCP1,e and promoted tumor growth. The, and further polarized into an M,TextQuoteSelector,TextPositionSelector,31149,31227,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:53.119073+00:00
ngmhprQ-EemielP4RFkOrA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1 may polarize into an M1 or M2 subset in a tumor, growthMacrophages recruited by , microenvironment. An M2 polariz,TextQuoteSelector,TextPositionSelector,27573,27625,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:44.047752+00:00
nV55SqVfEemy-MdtaTrBhQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,signal regulatory protein alpha ,"terleukin-10 (IL-10), CD47, and ",(SIRPα). The total amount of mRN,TextQuoteSelector,TextPositionSelector,40965,40997,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:16:08.978347+00:00
munVhqVXEemSmvcLJhq7-Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,mice,the cMSCs into immune deficient ," with human carcinoma cells, whi",TextQuoteSelector,TextPositionSelector,17129,17133,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:18:48.744686+00:00
mg9pGKVYEemn5gvJs9Aqew,b53nbDmi,https://europepmc.org/articles/PMC4991502/, cancer ,sion in the cMSCsThe MSCs affect,progression through a number of ,TextQuoteSelector,TextPositionSelector,18670,18678,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:25:56.907701+00:00
mI-B0rQ-Eem8tpOpj1p6iw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor-promoting effect by recruiting macrophages to tumor sites through the production of MCP1, the cMSCs probably exert their ,.cMSCs convert macrophages into ,TextQuoteSelector,TextPositionSelector,27385,27479,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:34.759660+00:00
lZEPfqVgEemyT0dfz2Uydg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,mice, of the bregma in the brains of ,". After the injection, the surfa",TextQuoteSelector,TextPositionSelector,38027,38031,MIS_OG,yes,[MIS_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:23:05.281996+00:00
kMcZgqVdEemV_ovfhJuv0A,b53nbDmi,https://europepmc.org/articles/PMC4991502/,rat,urchased from Sigma. Monoclonal , anti-mouse antibodies against C,TextQuoteSelector,TextPositionSelector,36143,36146,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:01:28.819023+00:00
k0OTErQ-EemIHR86e9M5mA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1 deficiency led to a significant reduction in CD206 positive macrophages in both tumor,low cytometry. We found that an , tissues and peripheral blood (F,TextQuoteSelector,TextPositionSelector,27100,27190,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:25.967855+00:00
jvS5bKVXEemUVi9PbiVkJA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD45,"D105 was observed, but CD34 and ", were down-regulated (data not s,TextQuoteSelector,TextPositionSelector,16888,16892,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:18:28.780298+00:00
jobw6qVWEemO-3_wWFFnIQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-1β,"ral classical M1 markers: TNFα, ",", and iNOS. An increased IL-1β a",TextQuoteSelector,TextPositionSelector,15399,15404,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:11:18.571105+00:00
jiU_ILQ-EemkLZ88og4ZUQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor promoting activity of the cMSCs was largely MCP1 ,C57BL/6 mice. We found that the ,dependent since it was significa,TextQuoteSelector,TextPositionSelector,26652,26707,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:17.414355+00:00
jG8z4qVTEemUQht9a8w3ew,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor,m cells by macrophages promotes , progression through immune supp,TextQuoteSelector,TextPositionSelector,6100,6105,WS_DS,yes,[WS_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:49:46.510177+00:00
iDH-OKeVEemSp_PCGldCzA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,chemokines , vivo. Examination of cytokines/,showed that the cMSCs acquired a,TextQuoteSelector,TextPositionSelector,10875,10886,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:47:08.596708+00:00
i8yDPLQ-EemwPYsMtxIXOg,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor favored by the cMSCs could be inhibited by MCP1 ,e. (C) The in vivo growth of the,siRNA. 4T1-FLUC tumor cell growt,TextQuoteSelector,TextPositionSelector,25583,25638,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:27:13.390161+00:00
hi9yzqVfEem-ZQ_O4qvfMg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,interleukin-10,", inflammatory zone 1 (FIZZ-1), "," (IL-10), CD47, and signal regul",TextQuoteSelector,TextPositionSelector,40931,40945,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:15:30.014936+00:00
gyBYSqVWEemEBwegV3VVRQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TNFα,f several classical M1 markers: ,", IL-1β, and iNOS. An increased ",TextQuoteSelector,TextPositionSelector,15393,15397,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:10:59.512763+00:00
gnX41rQ-EemLlC9hbN8F3g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1 deficiency on cMSCs tumor ,cted with MCP1 siRNA. Impact of ,promoting effects was detected. ,TextQuoteSelector,TextPositionSelector,25260,25291,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:57.698953+00:00
g5_f_qVZEem-Fls20yGKlw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-2,ConA followed by expansion with , for 72 hours. We co-cultured th,TextQuoteSelector,TextPositionSelector,21707,21711,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:32:28.860164+00:00
g3XGcqeVEemLNEs2lDf2pA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,cytokines, growth in vivo. Examination of ,/chemokines showed that the cMSC,TextQuoteSelector,TextPositionSelector,10865,10874,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-16T06:47:00.700649+00:00
g0iN0qVXEemyK3ftKDLrqQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD34,"D90 and CD105 was observed, but ", and CD45 were down-regulated (d,TextQuoteSelector,TextPositionSelector,16879,16883,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:18:09.079305+00:00
flZ51KVgEem4ImtbGYIXkA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,iNOS , in which mice received 1 × 106 ,siRNA treated cMSCs and 2 × 106 ,TextQuoteSelector,TextPositionSelector,39024,39029,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:22:26.360487+00:00
fEmVMLQ-EemqbU8Z-URIew,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Tumor-promoting effect of the cMSCs relied on the MCP1,pen in a separate windowFigure 4, to recruit TAMs(A) Ablation of ,TextQuoteSelector,TextPositionSelector,25019,25073,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:47.477383+00:00
ewwLfqVZEemMpiPe8wl92w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,ConA,splenocytes were activated with , followed by expansion with IL-2,TextQuoteSelector,TextPositionSelector,21675,21679,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:32:14.471986+00:00
eiqLdqVfEem3mqd3yBgo_Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,inflammatory zone 1,"MP-2), arginase type 1 (Arg-1), "," (FIZZ-1), interleukin-10 (IL-10",TextQuoteSelector,TextPositionSelector,40901,40920,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:15:09.969912+00:00
dx5YcLQ-EemBUt8-9aQCAg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs in recruiting CD45+ cells at tumor,e more effective than untreated ," sites (Figure ​(Figure2E),2E), ",TextQuoteSelector,TextPositionSelector,24186,24225,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:38.598643+00:00
dx5K2KVXEem8IVOUGHUqUA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD105 ,"ression of CD29, CD73, CD90 and ","was observed, but CD34 and CD45 ",TextQuoteSelector,TextPositionSelector,16855,16861,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:17:48.689666+00:00
ciQ-1qVaEem2ogNVBbSWpg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,C57BL/6 mice,s and 4T1-FLUC tumor cells into ,. We found that the tumor promot,TextQuoteSelector,TextPositionSelector,26620,26632,WS_OG,no,WS_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:39:09.024245+00:00
cgO8TqVdEemLLK9nl4pAWg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-15,"4, IL-6, IL-10, IL-12, IL-2 and "," were from Pepro Tech (London, U",TextQuoteSelector,TextPositionSelector,36040,36045,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:00:37.199282+00:00
cWm7uKVXEemdh6Ofaij4Iw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD90 ," High expression of CD29, CD73, ","and CD105 was observed, but CD34",TextQuoteSelector,TextPositionSelector,16846,16851,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:17:39.324056+00:00
cRF1vKVWEemTWz_fFGO9tQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,S1A,ker) remained unchanged (Figure ,). Macrophage M1 polarization wa,TextQuoteSelector,TextPositionSelector,15243,15246,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:10:29.228285+00:00
cJ3K0LQ-Eemz8PsdR9ac8w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1-mediated macrophage trafficking is critical for the tumor, (C) in tumors after treatments.,-promoting effects of the cMSCsA,TextQuoteSelector,TextPositionSelector,24032,24094,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:27.825707+00:00
bQvXsqVTEemgA9MCu0wj3g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,metastatic tumors,"n, TAMs isolated from solid and ", have a suppressive M2-like phen,TextQuoteSelector,TextPositionSelector,10189,10206,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:48:53.977429+00:00
b0xDRKVUEemK_QfIQ0J5ag,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Cancers,", cancer, MCP1Go to:INTRODUCTION", develop in complex tumor microe,TextQuoteSelector,TextPositionSelector,11502,11509,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:56:07.121989+00:00
aq8A-qVfEemySBPzG07LAA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,arginase type 1,"ix metalloproteinase-2 (MMP-2), "," (Arg-1), inflammatory zone 1 (F",TextQuoteSelector,TextPositionSelector,40876,40891,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:14:44.000734+00:00
ak66rrQ-EemLKJMqCcR4tA,b53nbDmi,https://europepmc.org/articles/PMC4991502/, iNOS siRNA did not support 4T1-FLUC tumor, cMSCs. (C) cMSCs transfected by, cell growth. (D) Quantification,TextQuoteSelector,TextPositionSelector,23897,23939,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:17.138349+00:00
a32z0KVXEemgEKNlPhFJ1Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD73," MSCs. High expression of CD29, ",", CD90 and CD105 was observed, b",TextQuoteSelector,TextPositionSelector,16840,16844,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:17:29.355621+00:00
_O1KiLQ-EemIIIdVM7Z3YA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"breast cancer cells, the cMSCs but not the untreated MSC remarkably increased the tumor",o-injected with MDA-MB-231-FLUC ,-initiating ability and tumor gr,TextQuoteSelector,TextPositionSelector,17244,17331,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:23.126079+00:00
ZmyWnqVdEemllXcfqQytsA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-12,"nterleukin (IL)-4, IL-6, IL-10, ",", IL-2 and IL-15 were from Pepro",TextQuoteSelector,TextPositionSelector,36024,36029,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:00:17.762328+00:00
Zh9dHKVXEemmy0MLlGjFSg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD29,of the MSCs. High expression of ,", CD73, CD90 and CD105 was obser",TextQuoteSelector,TextPositionSelector,16834,16838,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:17:20.236034+00:00
ZS4zlKVfEem65r_aMsZSiw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MIP-1β,ophage inflammatory protein-1β (,"), tumor necrosis factor-α (TNF-",TextQuoteSelector,TextPositionSelector,40774,40780,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:14:34.757646+00:00
YoE7vLQ-EemeUXclM_zZdg,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor favored by the cMSCs in vivo can be inhibited by iNOS, windowFigure 3The growth of the, siRNATo determine the effect of,TextQuoteSelector,TextPositionSelector,23358,23418,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:26:04.191105+00:00
XibG2rQ_Eemga3NsSkAGEQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/, MSCs-mediated tumor ,"However, the exact mechanisms of","growth are still debated, especi",TextQuoteSelector,TextPositionSelector,34037,34058,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:33:06.484448+00:00
XJRA8LQ-EemBT_NiRPh7jg,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor-promoting ability of the cMSCs was dependent upon the expression of iNOS ,"re, we demonstrated that the 4T1","(Figure 3C–3D). Therefore, these",TextQuoteSelector,TextPositionSelector,23064,23144,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:54.249317+00:00
Ws_uJrQ_EemLKg9uqbeHSA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs may be involved in cancer ,ious reports indicated that the ,initiation in vivo and the MSCs ,TextQuoteSelector,TextPositionSelector,33772,33803,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:33:00.578716+00:00
Wk0lRqVhEemcxffwmMn0MA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor ,siRNA treated cMSCs and 2 × 106 ,cells in 100 μl of PBS. Mice wer,TextQuoteSelector,TextPositionSelector,39197,39203,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:28:35.381084+00:00
WE1QfqVfEemdo7dltyrz1g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Macrophage inflammatory protein-1β,"chemoattractant protein (MCP1), "," (MIP-1β), tumor necrosis factor",TextQuoteSelector,TextPositionSelector,40738,40772,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:14:13.131315+00:00
VszwhqVXEemlay8DUqRFXQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,mouse,e marrow. The morphology of the , MSCs displayed a homogenous spi,TextQuoteSelector,TextPositionSelector,16685,16690,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:16:54.253040+00:00
Vg-aHKVTEemlcf8kPbJbiw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,carcinogenesis,in cancer. A protective role in , has been described for M1 macro,TextQuoteSelector,TextPositionSelector,10054,10068,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:48:15.340488+00:00
VMDj_qVeEemdnn9ChrYYeA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Animal ,iversity Health Science Center. ,experiments were performed accor,TextQuoteSelector,TextPositionSelector,37243,37250,MIS_OG,yes,[MIS_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:06:57.714039+00:00
V8xLirQ-EemLJ8eTZ98Jrw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor promotion of the required iNOS,creased (Figure S2).cMSCs exert ,High concentrations of nitric ox,TextQuoteSelector,TextPositionSelector,22009,22045,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:46.080507+00:00
UeBtKqVaEemBuCtU3dPG8w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP-1,ood of 4T1 bearing control mice., is the CCR2 ligand. The chemoki,TextQuoteSelector,TextPositionSelector,25882,25887,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:38:14.880725+00:00
UaLN4rQ-EemeUBvCqROLbg,b53nbDmi,https://europepmc.org/articles/PMC4991502/, MSCs in recruiting CD45+ cells to tumor,ore effective than the untreated, sites. In view of the immunosup,TextQuoteSelector,TextPositionSelector,21478,21518,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:35.895031+00:00
U-MWCqVZEemTYTtTaxddyw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TLRs,P < 0.01. (B) The expression of , of the cMSCs was assessed by re,TextQuoteSelector,TextPositionSelector,20132,20136,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:31:08.770294+00:00
TQpmULQ-Eem8SuMm3L-CVw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"CD45+ to identify tumor-associated bone marrow cells 14 days after co-injection with 4T1-FLUC cells and cMSCs or untreated MSCs, and found that there was a great expansion of the populations of CD45+ cells in tumors",rrow derived cells. We employed ,", an effect that was dramaticall",TextQuoteSelector,TextPositionSelector,21095,21310,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:28.138610+00:00
TLXSuqVTEemcl1fgUkR9WA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,cancer,ective or pathogenic effects in ,. A protective role in carcinoge,TextQuoteSelector,TextPositionSelector,10025,10031,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:47:59.656863+00:00
S_VPGKVYEemyb4sxEn208w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,malignant glioblastoma, significant tumor promotion of ," U87MG-FLUC cells (Figure 1C, 1F",TextQuoteSelector,TextPositionSelector,17713,17735,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:23:45.869765+00:00
SZRy5LQ_Eem8vstumyMwdg,b53nbDmi,https://europepmc.org/articles/PMC4991502/," tumor growth, recruit CD45",MSCs could significantly promote, positive bone marrow cells in v,TextQuoteSelector,TextPositionSelector,33398,33425,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:32:31.966753+00:00
S4pkxKVXEemIE1uMOjR_OA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,murine ," cMSCs, MSCs were isolated from ",bone marrow. The morphology of t,TextQuoteSelector,TextPositionSelector,16643,16650,MIS_OG,yes,[MIS_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:16:35.796447+00:00
RyJQpLQ-EemGm4Nflx5bCQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"MSCs to adopt a regulatory phenotype, and the cMSCs promoted tumor growth by iNOS and MCP1", macrophages could activate the ,". Therefore, this study revealed",TextQuoteSelector,TextPositionSelector,14584,14674,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:18.216222+00:00
RomRvqVZEemjC78oWeXIBA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,breast tumors,ed) and DAPI (blue) in 4T1-FLUC , 14 days after co-injection. Sca,TextQuoteSelector,TextPositionSelector,20713,20726,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:30:46.272583+00:00
RjSGUKVfEemrN0M-wkAc1g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,monocyte chemoattractant protein,"including interleukin-6 (IL-6), "," (MCP1), Macrophage inflammatory",TextQuoteSelector,TextPositionSelector,40697,40729,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:13:42.677485+00:00
RjLgzLQ_EemqdZszJloDJA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor growth and metastasis in contrast to MSC,mune competent model attenuated ,- or MSC2-treated animals in whi,TextQuoteSelector,TextPositionSelector,33202,33248,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:32:26.334981+00:00
RMw1jKVgEemvUv-vxNqhRw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,firefly , lentiviral vector containing a ,luciferase reporter gene were fi,TextQuoteSelector,TextPositionSelector,36659,36667,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:20:49.929281+00:00
Qj5VALQ_EemqdIsUUVqfGg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor promoting pathway is the MSCs,rophages.The key factor of this ,". Recently, the immune modulator",TextQuoteSelector,TextPositionSelector,32476,32511,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:32:19.523655+00:00
Qdzf1KVWEemi-2MNr52i5A,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD11b,"reased, while the expression of ", (macrophage marker) remained un,TextQuoteSelector,TextPositionSelector,15190,15195,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:09:09.785602+00:00
Qb67XLQ-EemshHsGxQloNA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"MCP1 expression in cMSCs, the tumor",P1. Consistent with an elevated ,-promoting effect of the cMSCs d,TextQuoteSelector,TextPositionSelector,11013,11048,YGD,no,YGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:25:09.197660+00:00
PpFeUKVfEemyhlcmkwTfvQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,interleukin-6,"e listed in Table S1, including "," (IL-6), monocyte chemoattractan",TextQuoteSelector,TextPositionSelector,40675,40688,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:13:29.966202+00:00
PjM6hLQ_EemjGateqJTj8Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor cells via MSCs,nk between the M1 macrophage and,.Open in a separate windowFigure,TextQuoteSelector,TextPositionSelector,31427,31448,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:32:12.876195+00:00
PEGslKVgEemdqMfVhmk3SQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,luciferase,ral vector containing a firefly , reporter gene were first select,TextQuoteSelector,TextPositionSelector,36667,36677,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:20:35.601801+00:00
P7euJqVTEemTAFd0GvmyfQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor,nt and progression is linked to ,-associated macrophages (TAMs). ,TextQuoteSelector,TextPositionSelector,9915,9920,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:47:37.856148+00:00
OiBzCLQ_EemjGP9uXV_mKQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/," cancer development induced by inflammation: when the microenvironment became M1 pro-inflammatory, the MSCs acquired a regulatory phenotype and promoted tumor ",indings demonstrated an event of,growth. The tumor-promoting abil,TextQuoteSelector,TextPositionSelector,30979,31138,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:32:05.950782+00:00
OHAOPqVcEemlgZuMGrXLfA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,graft-versus-host disease,ta found that the prevention of , by the MSCs was dependent on iN,TextQuoteSelector,TextPositionSelector,34173,34198,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:51:51.217617+00:00
OFGIZqVWEems3BcNHX0B8g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,FACS,acrophage marker) examined by a ," analysis clearly increased, whi",TextQuoteSelector,TextPositionSelector,15133,15137,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:08:53.935113+00:00
Nil6zKVaEemLHF8xvgZysg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CCR2, ligand. The chemokine receptor , is known to be expressed on mon,TextQuoteSelector,TextPositionSelector,25931,25935,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:37:28.290380+00:00
NLmsSrQ_Eem8LO-MBlsDuA,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor sites in mice who were administered cMSCs and were treated by MCP1 ,ive macrophages in the blood and,siRNA or control siRNA were exam,TextQuoteSelector,TextPositionSelector,26953,27027,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:56.739133+00:00
NDTyvqVfEemMuUtK8TiPIg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,DNase I,en) and treated with RNase-free ," (Qiagen, USA). First-strand cDN",TextQuoteSelector,TextPositionSelector,40448,40455,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:13:12.590854+00:00
MEM8drQ_Eem8UofQhNJAww,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MCP1 in tumor ,ish the role of cMSCs-expressed ,growth promotion and macrophage ,TextQuoteSelector,TextPositionSelector,26478,26492,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:49.320592+00:00
LbuC2qVgEemjJptjZIQDqw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor necrosis factor-α,"flammatory protein-1β (MIP-1β), "," (TNF-α), interleukin-19 (IL-19)",TextQuoteSelector,TextPositionSelector,40783,40806,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:20:11.119875+00:00
Lb2QHKVfEemyRu_6ldI3Lw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,RNase,t (Invitrogen) and treated with ,"-free DNase I (Qiagen, USA). Fir",TextQuoteSelector,TextPositionSelector,40437,40442,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:13:01.763913+00:00
LUT-1KVXEemObTPdjtQEOw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,S1B,ed to the control group (Figure ,"). Therefore, incubation of macr",TextQuoteSelector,TextPositionSelector,16372,16375,WT_GP,no,[WT_GP],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:15:44.920916+00:00
LChZvrQ_Eem8uwsYXxL4sw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"tumor-promoting effect of the cMSCs, we depleted systemic monocytes/macrophages with clodronate liposomes (Clo-Lip) followed by injecting mixtures of cMSCs or MSCs",ocytes/macrophages mediated the , with 4T1 tumor cells into mice ,TextQuoteSelector,TextPositionSelector,24482,24645,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:42.651779+00:00
L8X1lKVeEemIDT_SIgZEzQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,C57BL/6 nude mice,d 6–10 weeks.Animal modelFemale , (6–7 weeks old) were purchased ,TextQuoteSelector,TextPositionSelector,37108,37125,WS_OG,no,WS_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:05:55.653135+00:00
JXvUEKVdEemYQfdpBlbSUA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,interleukin (IL)-4,"ulating factor (GM-CSF), M-CSF, ",", IL-6, IL-10, IL-12, IL-2 and I",TextQuoteSelector,TextPositionSelector,35991,36009,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:58:28.905446+00:00
JPkVnKVZEemTEGO5FZw_Lg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TLR2,"ght be affected, and found that ",", TLR3, and TLR4 were induced at",TextQuoteSelector,TextPositionSelector,19481,19485,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:29:49.954676+00:00
JMCO0LQ_EemW_ad5VaUOJg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor-promoting effect of MSCs,crophages are essential for the , isolated from tumor sites [14].,TextQuoteSelector,TextPositionSelector,24363,24393,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:30.195612+00:00
JCmVhqVWEemOaA8y4FfBlQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,LPS,64.7 cell exposure to IFN-γ and , drive M1 polarization with pote,TextQuoteSelector,TextPositionSelector,14952,14955,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:08:20.220431+00:00
IFwdeKVYEemy4mezf9q1hw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor,cMSCs also led to a significant , promotion of malignant glioblas,TextQuoteSelector,TextPositionSelector,17694,17699,WS_DS,yes,[WS_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:22:32.826867+00:00
HebGYqVbEemTZkfXu6Ccdw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TNF-α,hat the concomitant presence of , and IFN-γ could induce the immu,TextQuoteSelector,TextPositionSelector,32046,32051,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:43:57.199779+00:00
HGrlvrQ_EemQV3uRPlkwRA,b53nbDmi,https://europepmc.org/articles/PMC4991502/, tumor-promoting effect and how they differ from untreated MSCs,gate how the cMSCs achieve their,", we examined the gene expressio",TextQuoteSelector,TextPositionSelector,18930,18993,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:16.144217+00:00
HEimRqVaEemjDoOFcKt2kg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CCR2 ligand,aring control mice.MCP-1 is the ,. The chemokine receptor CCR2 is,TextQuoteSelector,TextPositionSelector,25895,25906,WS_GP,no,WS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:36:44.832908+00:00
HDUvpKVeEemSrZ-CIqD6lA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Murine,mmune-deficient or normal mice. , macrophage-like cells RAW264.7 ,TextQuoteSelector,TextPositionSelector,36778,36784,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:05:22.736314+00:00
H-om0rQ_Eem5pxd4ZzBvEQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/, Tumor-associated leukocytes differ among the cMSCs and MSCs,ts. *P < 0.05 versus MSCs. (E–F), treated groups. (E) Immunohisto,TextQuoteSelector,TextPositionSelector,20560,20620,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:21.990826+00:00
GDwYmqVZEemvQRMxe5-v1g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSC2,LR4-primed MSC1 and TLR3-primed , [17]. We used real-time PCR to ,TextQuoteSelector,TextPositionSelector,19376,19380,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:29:28.690731+00:00
FzFK-qVfEemaNVO1HcKqiw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Animals ,re transfected with MCP1 siRNA. ,were divided into two groups (n ,TextQuoteSelector,TextPositionSelector,39653,39661,MIS_OG,no,MIS_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:12:23.805754+00:00
Fkk8jKVWEemIDru5G181Pw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IFN-γ,-line RAW264.7 cell exposure to , and LPS drive M1 polarization w,TextQuoteSelector,TextPositionSelector,14942,14947,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:07:56.935950+00:00
FFIPprQ_EemLldPvWwgqcA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumors after treatments. *P < 0.05 vs. MSCs ,"t (D), liver (E), and brain (F) ",group; #P < 0.05 vs. PBS group.S,TextQuoteSelector,TextPositionSelector,18501,18545,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:02.411059+00:00
F-gLDLQ_EembXsPu5Qao5w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs affect cancer ,kine expression in the cMSCsThe ,progression through a number of ,TextQuoteSelector,TextPositionSelector,18659,18678,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:31:08.546047+00:00
Ett8PqVdEemrNSfdm9kVvw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,M-CSF,"ny stimulating factor (GM-CSF), ",", interleukin (IL)-4, IL-6, IL-1",TextQuoteSelector,TextPositionSelector,35984,35989,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:57:57.560945+00:00
ERe8ALQ_Eem08VdmpNgu4g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"cancer mice co-injected with cMSCs, MSCs","t (A), liver (B), and brain (C) ", or PBS. cMSCs -treated mice dis,TextQuoteSelector,TextPositionSelector,18278,18318,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:56.858166+00:00
DjwP9KVdEemgJicpe1oclQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,GM-CSF,hage-colony stimulating factor (,"), M-CSF, interleukin (IL)-4, IL",TextQuoteSelector,TextPositionSelector,35975,35981,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:57:49.892634+00:00
CuwBJKVdEemjHifDGav56Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,granulocyte macrophage-colony stimulating factor," mouse TNFα, interferon (IFNγ), "," (GM-CSF), M-CSF, interleukin (I",TextQuoteSelector,TextPositionSelector,35925,35973,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:57:44.194460+00:00
CoFDSLQ_Eem20E9XD1fBnA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor growth in vivo to a greater extent than untreated-MSCs,te windowFigure 1cMSCs promoted ,(A–C) D-Luciferin induced biolum,TextQuoteSelector,TextPositionSelector,18127,18187,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:46.177088+00:00
CJEK7KVXEemQqM8yMapSpw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD47,acrophages. The interactions of ,-SIRPα form a barrier for antibo,TextQuoteSelector,TextPositionSelector,15889,15893,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:14:43.275809+00:00
C8WQ8KVeEemZGGe8Jm4Z0Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/, glioma,"hepatoma cells, human U87MG-FLUC", cells and murine 4T1-FLUC breas,TextQuoteSelector,TextPositionSelector,36543,36550,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:04:55.163228+00:00
BqufFrQ_EemW-1-5DHP1tQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumor growth in comparison to the untreated MSCs,ed greater potential to promote ,.Open in a separate windowFigure,TextQuoteSelector,TextPositionSelector,18030,18078,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:39.734644+00:00
AaxjqqVZEemy5UdCfVLCXA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TLR3,R-priming: TLR4-primed MSC1 and ,-primed MSC2 [17]. We used real-,TextQuoteSelector,TextPositionSelector,19364,19368,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:28:50.840676+00:00
AFXAEKVYEemIG5d-_M-ySA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,hepatocellular carcinoma,a tumor-promoting effect in the , model as compared to the untrea,TextQuoteSelector,TextPositionSelector,17562,17586,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:21:39.093112+00:00
ADYZQKVdEemgJZvXuqGQbQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IFNγ,"mbinant mouse TNFα, interferon (","), granulocyte macrophage-colony",TextQuoteSelector,TextPositionSelector,35918,35922,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:57:26.369278+00:00
ADGyBrQ_EemqoiN3aJ_CBg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"breast cancer model, the cMSCs caused a tumor-promoting effect in the hepatocellular carcinoma model as compared to the untreated control MSCs", growth in vivo. Similar to the ," group (Figure 1B, 1E). The cMSC",TextQuoteSelector,TextPositionSelector,17492,17634,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:28.744354+00:00
A3hGeLQ_EemlF7-7mMz0Vw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs in promoting tumor ,more effective than the control ,growth (data not shown). Therefo,TextQuoteSelector,TextPositionSelector,17921,17945,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:34.088267+00:00
A1fpfKVeEem8Oa_9iTmR4Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,hepatoma,"-FLUC cells, human HCC-LM3-FLUC "," cells, human U87MG-FLUC glioma ",TextQuoteSelector,TextPositionSelector,36511,36519,CRT_DS,no,CRT_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:04:40.994798+00:00
9wroYqVeEem-ZJOBuqmHyw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,nude mice,e or coupled with the MSCs into ,. The MSCs were treated with M1 ,TextQuoteSelector,TextPositionSelector,38298,38307,CRT_OG,no,CRT_OG,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:11:29.883434+00:00
8fQn5KVZEemco88WdkKQxA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CD206 ,etry data show the frequency of ,macrophages from the tumor and p,TextQuoteSelector,TextPositionSelector,25800,25806,MIS_GP,yes,[MIS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:35:33.944082+00:00
8_0xXrQ-EemRTvNaDzHA2w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs to promote tumor,d more potential than untreated-, growthMacrophage cell-line RAW2,TextQuoteSelector,TextPositionSelector,14867,14888,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:08.218107+00:00
8PF7jLQ-EemBVUvLAC_2MA,b53nbDmi,https://europepmc.org/articles/PMC4991502/, MSCs sensed and controlled inflammation to promote tumor ,"re, this study revealed that the",growth in a pro-inflammatory env,TextQuoteSelector,TextPositionSelector,14715,14773,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:03.007209+00:00
8Nu0oKVXEemcrI_RYiXmXQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,HCC, of the cMSCs on hepatocellular ,-LM3-FLUC tumor growth in vivo. ,TextQuoteSelector,TextPositionSelector,17442,17445,WT_GP,yes,[WT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:21:13.033302+00:00
7vObbKVhEemcvV85oo3MMw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MMP-2,"9), matrix metalloproteinase-2 (","), arginase type 1 (Arg-1), infl",TextQuoteSelector,TextPositionSelector,40868,40873,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:32:44.847339+00:00
7ZKm8qVfEem7QHP4X9kp1w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,F4/80,MA) and FITC-labeled anti-mouse ," (Abcam, Cambridge, MA).Statisti",TextQuoteSelector,TextPositionSelector,43836,43841,MIS_GP,no,MIS_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:18:23.601014+00:00
7XGEFrQ-EemeU_eNTzFwLw,b53nbDmi,https://europepmc.org/articles/PMC4991502/, MSCs in tumor ,effects of M1 macrophages on the,"growth, we treated MSCs with con",TextQuoteSelector,TextPositionSelector,14280,14295,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:57.253656+00:00
6x08cqVYEems5gsgDPApJQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TLR4,radigm by specific TLR-priming: ,-primed MSC1 and TLR3-primed MSC,TextQuoteSelector,TextPositionSelector,19343,19347,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:28:12.903005+00:00
6mZDLrQ-Eem2ztM_8A1HJA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs could favor a tumor, was to investigate whether the , to escape from immunologic surv,TextQuoteSelector,TextPositionSelector,14123,14147,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:52.298636+00:00
6cOOuKVcEem8MSOoxSBq3w,b53nbDmi,https://europepmc.org/articles/PMC4991502/,interferon,"ReagentsRecombinant mouse TNFα, "," (IFNγ), granulocyte macrophage-",TextQuoteSelector,TextPositionSelector,35906,35916,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:56:48.598205+00:00
5vjhYLQ-Eem2zQe8jMovYg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,inflammation and the MSCs ,s in initiating and controlling ,could influence macrophage funct,TextQuoteSelector,TextPositionSelector,13672,13698,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:46.562459+00:00
5WH3aqVSEemD8KuP59fI9g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Cancer,r articles in PMC.Go to:Abstract, development and progression is ,TextQuoteSelector,TextPositionSelector,9867,9873,MIS_DS,yes,[MIS_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T09:45:06.388714+00:00
5P3VsqVZEemyd__6xeJMMA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,breast carcinoma,d by BLI after establishing the , model. (D) Representative flow ,TextQuoteSelector,TextPositionSelector,25715,25731,CRT_DS,yes,[CRT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:35:12.228783+00:00
5M2heLQ-EemFs-9LD7TQTA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSCs are one of the major components of the tumor ,nic at the onset of disease [5].,stroma and there is a close inte,TextQuoteSelector,TextPositionSelector,13071,13121,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:42.794378+00:00
5D_DMKVhEemcx5sM_oyuYg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,matrix metalloproteinase-2,"TNF-α), interleukin-19 (IL-19), "," (MMP-2), arginase type 1 (Arg-1",TextQuoteSelector,TextPositionSelector,40840,40866,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:32:26.770090+00:00
4k0L4KVYEemgFnMjpZ9h-Q,b53nbDmi,https://europepmc.org/articles/PMC4991502/,TLR,a new MSCs paradigm by specific ,-priming: TLR4-primed MSC1 and T,TextQuoteSelector,TextPositionSelector,19330,19333,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:27:58.207547+00:00
4F17AqVeEemLLt8MWrAbQQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,brain carcinoma,"umor growth, breast, liver, and ", cells were injected either alon,TextQuoteSelector,TextPositionSelector,38219,38234,WS_DS,no,WS_DS,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:10:51.831898+00:00
3MwDdqVWEemy3P9WRS3VUQ,b53nbDmi,https://europepmc.org/articles/PMC4991502/,SIRPα,of signal regulatory protein-a (,) was significantly reduced (Fig,TextQuoteSelector,TextPositionSelector,15767,15772,WS_GP,yes,[WS_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:13:29.961640+00:00
38kherQ-Eemkk6NEjE_eQA,b53nbDmi,https://europepmc.org/articles/PMC4991502/," MSCs, the vasculature and various other components of a tumor","phages, immune suppressor cells,",-supportive microenvironment.Mac,TextQuoteSelector,TextPositionSelector,12034,12096,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:34.320104+00:00
2LqmtKVYEem9VcNI8FZMyw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CXCL10,"owever, the levels of CXCL9 and ", were lower (Figure ​(Figure2A).,TextQuoteSelector,TextPositionSelector,19229,19235,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:27:42.147567+00:00
29GsDrQ-Eem8T9Pwzlt9zw,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"Cancers develop in complex tumor microenvironments, which include cells such as endothelial cells, immune cells, tumor-associated macrophages (TAMs), and mesenchymal stem cells (MSCs",", cancer, MCP1Go to:INTRODUCTION",) [1]. Non-cancerous stromal cel,TextQuoteSelector,TextPositionSelector,11502,11684,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:27.717659+00:00
18ys2KVZEem62gepGM07QA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,Animals,promoting effects was detected. , were divided into the si-MCP1/c,TextQuoteSelector,TextPositionSelector,25323,25330,CRT_OG,yes,[CRT_OG][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:34:50.084098+00:00
18U4JLQ-EemIHs872a57mg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,"inflammation type in tumor microenvironment, the MSCs ",macrophages changed into M1 pro-,would act as poor sensors and sw,TextQuoteSelector,TextPositionSelector,11290,11344,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:20.913277+00:00
0_15wrQ-EemQeGe778L4rw,b53nbDmi,https://europepmc.org/articles/PMC4991502/, MSCs educated by M1 condition medium (cMSCs) possessed a greatly enhanced ability in promoting tumor,of M1 macrophages. We found that, growth in vivo. Examination of ,TextQuoteSelector,TextPositionSelector,10732,10833,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:29:14.555622+00:00
0Vp1hKVYEem1V7e7rz4lBA,b53nbDmi,https://europepmc.org/articles/PMC4991502/,CXCL9,"ed MSCs. However, the levels of ", and CXCL10 were lower (Figure ​,TextQuoteSelector,TextPositionSelector,19219,19224,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:27:29.683061+00:00
0Qi3IqVhEemdrNOflFTqJg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,IL-19,"ctor-α (TNF-α), interleukin-19 (","), matrix metalloproteinase-2 (M",TextQuoteSelector,TextPositionSelector,40832,40837,CRT_GP,no,CRT_GP,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T11:31:54.701033+00:00
-swKaKVYEemcriu8OvEwzg,b53nbDmi,https://europepmc.org/articles/PMC4991502/,MSC1,ecific TLR-priming: TLR4-primed , and TLR3-primed MSC2 [17]. We u,TextQuoteSelector,TextPositionSelector,19355,19359,CRT_GP,yes,[CRT_GP][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:28:39.186454+00:00
-WLM2rQ-Eem8zkNkGKFU5A,b53nbDmi,https://europepmc.org/articles/PMC4991502/," tumor growth, we injected the cMSCs into immune deficient mice with human carcinoma cells, while untreated MSCs",er the cMSCs could promote human, were used as controls. When co-,TextQuoteSelector,TextPositionSelector,17070,17182,NGD,no,NGD,,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-08-01T09:30:17.239980+00:00
-KwM1qVaEem4FO_ZEK6x6g,b53nbDmi,https://europepmc.org/articles/PMC4991502/,tumorigenesis,ory responses which can promote ,. Our findings demonstrated an e,TextQuoteSelector,TextPositionSelector,30927,30940,WT_DS,yes,[WT_DS][ALL],,acct:vanitha_hg@hypothes.is,Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.,2019-07-13T10:42:54.627018+00:00
